TQC2938 injection

DRUG3 trials

Sponsors

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

Conditions

AsthmaChronic Obstructive Pulmonary DiseaseSeasonal Allergic Rhinitis

Phase 1

A Clinical Trial of TQC2938 Injection in Healthy Adult Subjects

Active, not recruitingNCT06449859

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Asthma

Start: 2023-06-13End: 2024-11-30Target: 84Updated: 2024-06-10

Phase 2

A Clinical Study to Evaluate the Efficacy and Safety of TQC2938 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Active, not recruitingNCT06789289

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Chronic Obstructive Pulmonary Disease

Start: 2025-03-17End: 2027-12-01Updated: 2026-04-07

Clinical Trial of TQC2938 Injection in Patients With Seasonal Allergic Rhinitis

CompletedNCT07052097

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.Seasonal Allergic Rhinitis

Start: 2025-07-31End: 2025-11-28Updated: 2026-02-10